Hello and welcome to another edition of Health Matters.

On this episode, we are going to be talking about something that is very, very crucial to all of us,

because it's going to affect all of us at some point or another.

And that's going to be arthritis.

But not only are we talking about arthritis.

We're talking about a breakthrough in arthritis.

When I say breakthrough, soundy alarms.

This is a good one.

So anybody who follows me knows I'm very much into regeneration medicine and new advances.

And what I'm going to go over today is something that is new, but not new.

And it really has the potential to change patients' lives in a way that we haven't seen

before for a condition that we normally relatively cannot control.

What is it? What are you talking about? All right. I'm talking about A2M for arthritis treatment. I will

explain exactly what A2M is. I promise you. So as we all know, arthritis is one of the most

common joint conditions faced by millions of Americans worldwide, affecting the quality

of your life, limiting your day-to-day function. Current advances in medical research have helped make us understand

the molecular mechanism behind arthritis, including how certain proteins, such as alpha-2 macroglobulin, better known as A2M, how this plays a key role in its relationship

where arthritis and how it affects the body.

And we're really going to get into how it affects the body.

The different conditions do you associate with the treatment options and managing arthritis

through?

So what is A2M?

...